|
CLINICAL and HEALTH PROFESSIONALS:
HEALTH PLANS, PROVIDERS and PAYORS
|
Providers and Payors fully appreciate the value of improving medication adherence:
Without help in remembering, medication mismanagement results in:
- Extra ER visits
- More hospitalizations
- Costlier treatments
- More health service utilizations
- More severe and frequent episodes of care
- Provider/payor loss of competitiveness over time.
As health costs have shown double-digit growth for 5 successive years, payors are increasingly committed to driving down costs -- while simultaneously improving members’ health outcomes.
|
Insurance and health plans, private and public payors have ample reason to offer the highly cost-effective MedSignals system with its strong evidence-based performance in improving adherence and, consequently, the health of members.
MedSignals demonstrates:
- Fewer days with missed doses
- Fewer doses missed throughout an episode of care
- More “on-time” doses -- improved “timing compliance”
- High satisfaction and usability ratings as an easy-to-use reminder at pill-time
- Improved outcomes
|
Call for P.E.P.M. rates.
 |
What MedSignals provides payors and providers:
- Monitoring medication adherence as “the
new vital sign”
- Aggregate dashboards, charting individual and group adherence records
- Identifying at-risk patents, based on your defined rules
- HIPAA-compliant reporting by numerical schema only --no personal IDs attached to files
- Optimal communications service, using members’ own reliable, secured telephone lines, rather than costlier, vulnerable wireless services
- Co-branding options, with your logo prominently displayed on the cradle
- Device model and functions matched to specific disease states and demographics. Ask for more on customized models in quantities.
- Improved competitiveness.
UNIQUE FUNCTIONS SERVING SPECIFIC PROVIDERS:
- Health Plans
- Employer Groups
- Disease Management Organizations
- Assisted Living environments
- Home Health Agencies
LINKS relavant to Payors, Providers, Professionals:
GROUP MANAGEMENT
'PILL SPLITTING
' CUTS DRUG COSTS FOR PATIENTS, HEALTH PLANS by Carolyn Colwell, Washington Post
MONDAY, June 18 (HealthDay News) -- A practice patients often use to cut down on drug costs, called "pill splitting," can also save money for insurance companies and employers, a study of the University of Michigan's own health benefit plan shows. Read More
STUDY FINDS STAGGERING COST OF TREATING DIABETICS by Bill Berkrot, Reuters
NEW YORK (Reuters) - One out of every eight U.S. federal health care dollars is spent treating people with diabetes, a study found, and advocates are calling for the creation of a government post to oversee coordination of spending on treatment and prevention among federal agencies. Read More
MEN'S DIABETES
DEATHS DECLINE by Will Dunham, Reuters in Boston Globe
WASHINGTON -- The death rate for men with diabetes has fallen sharply in the United States since the early 1970s even as more people develop the disease, but women are not making the same progress, researchers said yesterday. The researchers speculated that women might not be getting the same care for heart disease as men. Diabetes is the sixth-leading cause of death in the United States. Read More
STUDY: MOST PATIENTS GIVE INACCURATE DRUG NAMES TO
DOCTOR
Many doctors may be getting the wrong information when it comes to patients listing
what drugs they are taking, researchers revealed. A study found that about 40% of
119 patients, some of whom had adequate health literacy, could not recall exactly
what drugs they were taking. Experts warned that inaccuracies could lead to drug
interactions or the undertreatment of chronic illnesses. Read More
|